# ZWI Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/zwi-therapeutics

- Industry: Biotechnology
- Headquarters: Watertown, US
- Website: www.zwitx.com
- Total disclosed funding: $5M
- Latest round: Series A (Mar 17, 2021)
- Investors on record: 2

## About

Established in 2020 and based in Massachusetts, US, ZWI Therapeutics, Inc. provides therapeutics i.e. novel proteins developed using their zwitterionic polymer technology. As of 2024, the company is headed by its CEO Ed Mascioli. In January 2024, the firm raised USD 10 million in Series A funding from investors Co-win Ventures and Healthcare Partners.

The company offers a superior polymer, polyCarboxyBetaine (pCB) which has physio-chemical properties and helps in reducing immunogenicity. The firm polymer technology helps in the development of nanoparticles. Moreover, the firm pCB helps in developing hydrogel which has multiple applications such as cellular therapies, etc.

## Funding rounds

- Series A, Mar 17, 2021, $5M — Co-Win Ventures, Sherpa Healthcare Partners

## Investors

- Co-Win Ventures (https://capitalatlas.ai/funds/co-win-ventures) — Series A
- Sherpa Healthcare Partners (https://capitalatlas.ai/funds/sherpa-healthcare-partners) — Series A